CD4 and myeloid sarcoma: We analyzed the high-coverage whole-exome sequencing data of sorted CD4+ and CD8+ T lymphocytes from 16 control individuals and 21 MS patients (the median coverage across the exome had median [min, max] across all samples of 369× [218×, 475×], Table 1).